$263.86 -9.41 (%) Biogen Inc - NASDAQ

Feb. 5, 2016 | 04:00 PM

Partner Headlines

  1. Nike To Facebook: Frank Caruso Projects Long-Term Earnings Growth

    IBD | Feb. 5, 2016 | 19:42PM EST
  2. LinkedIn Downgraded; Biotechs Initiated; Tableau PT Cut

    IBD | Feb. 5, 2016 | 09:16AM EST
  3. Maybe Some Good News For A Big Biotech ETF

    Benzinga | Jan. 29, 2016 | 08:39AM EST
  4. Sobi to present new interim ASPIRE data at EAHAD congress suggesting that patients can reduce bleeding rates with long-term Elocta treatment

    Benzinga | Jan. 28, 2016 | 04:27AM EST
  5. Earnings Recap For January 27

    Benzinga | Jan. 27, 2016 | 17:17PM EST
  6. Apple and Boeing Earnings, Plus Oil Drag, Combine to Dent Stocks

    Benzinga | Jan. 27, 2016 | 11:38AM EST
  7. Biogen's Stock Pops Following Better-Than-Expected Q4 Results

    Benzinga | Jan. 27, 2016 | 08:37AM EST
  8. 10 Stocks Moving In Wednesday's Pre-Market Session

    Benzinga | Jan. 27, 2016 | 08:26AM EST
  9. Earnings Scheduled For January 27, 2016

    Benzinga | Jan. 27, 2016 | 04:05AM EST
  10. Big Earnings Expectations For Big Biotech

    Benzinga | Jan. 24, 2016 | 16:55PM EST
  11. Biogen Ticks Up Following EU Marketing Authorization Of Benepali

    Benzinga | Jan. 19, 2016 | 08:39AM EST
  12. Biogen, Samsung JV Announces Etanercept Biosimilar Referencing Enbrel, BENEPALI, Approved in EU

    Benzinga | Jan. 17, 2016 | 09:18AM EST
  13. Stocks Reverse Higher To Big Gains; Intel Falls After Q4 Results

    IBD | Jan. 14, 2016 | 16:29PM EST
  14. This Week Is Paramount For Biotech Stocks

    Benzinga | Jan. 11, 2016 | 13:10PM EST
  15. Richard Snow Makes Huge Increases in Big-Name Stocks

    GuruFocus | Jan. 8, 2016 | 14:57PM EST
  16. Jean Hynes Finds Her Pot of Gold

    GuruFocus | Jan. 7, 2016 | 11:01AM EST
  17. Jim Cramer Gives His Opinion On Lockheed Martin And Gilead Sciences

    Benzinga | Jan. 7, 2016 | 06:35AM EST
  18. Not All Of Clinton's Policies Are Bad For Pharmaceuticals

    Benzinga | Dec. 23, 2015 | 14:13PM EST
  19. GoPro Downgraded, Ambarella PT Cut, Biotechs Are Buys

    IBD | Dec. 4, 2015 | 08:53AM EST
  20. Early Global News: Virtual Reality Market Getting Really Big, Facebook To Sell You Concert Tickets, And More

    Benzinga | Dec. 4, 2015 | 07:37AM EST
  21. Sanofi chips at Biogen share

    IBD | Nov. 30, 2015 | 18:53PM EST
  22. Sanofi Chipping Away At Biogen's MS Dominance

    IBD | Nov. 30, 2015 | 11:32AM EST
  23. Biotechs Weaken, But These Names Have Bullish Charts

    IBD | Nov. 25, 2015 | 17:19PM EST
  24. Sobi and Biogen's Elocta Approved by EC for Treatment of Haemophilia A

    Benzinga | Nov. 24, 2015 | 04:19AM EST
  25. Stocks Quietly Higher; JD.com Clears Key Resistance

    IBD | Nov. 23, 2015 | 11:59AM EST
  26. PRIMECAP Sells Stake in Technology Company

    GuruFocus | Nov. 16, 2015 | 17:04PM EST
  27. Vanguard Raises Stakes in Biogen, Mylan, Merck

    GuruFocus | Nov. 15, 2015 | 13:10PM EST
  28. Biogen Among Murray Stahl's Holdings With Growing Earnings

    GuruFocus | Nov. 11, 2015 | 18:06PM EST
  29. 10 S&P 500 Companies With Green Operations

    Benzinga | Nov. 10, 2015 | 15:10PM EST
  30. Roche Touts New MS Drug As Legacy Players Hit Snags

    IBD | Nov. 3, 2015 | 08:02AM EST
  31. Biogen's Breach Of 50-Day Line Was Clear Sell Signal

    IBD | Nov. 2, 2015 | 16:23PM EST
  32. Vanguard Health Care Fund Buys Biogen and Mylan, Cuts Pfizer

    GuruFocus | Nov. 2, 2015 | 12:33PM EST
  33. Biotechs Among Stocks That Insiders Have Been Buying Lately

    Benzinga | Nov. 2, 2015 | 11:53AM EST
  34. Biogen Is a Bargain

    GuruFocus | Oct. 29, 2015 | 13:55PM EST
  35. Wild Short Interest Swings For Three Top Biotech Stocks

    Benzinga | Oct. 28, 2015 | 07:57AM EST
  36. Apple Upgraded To Buy; Amazon, McDonald's PTs Hiked

    IBD | Oct. 23, 2015 | 08:57AM EST
  37. Hurricane Hillary Shifts Left, Slamming More Stocks

    IBD | Oct. 22, 2015 | 15:52PM EST
  38. Biogen tops Q3, will cut jobs

    IBD | Oct. 21, 2015 | 18:49PM EST
  39. Biogen Volatile After Q3 Beat, Raised Guidance And Disappointing Phase 3 Study

    Benzinga | Oct. 21, 2015 | 14:48PM EST
  40. Why Biogen Stock Is Having A Huge Day

    Benzinga | Oct. 21, 2015 | 14:27PM EST
  41. Biogen Beats Q3 Views, Cuts Workforce, Lifts Guidance

    IBD | Oct. 21, 2015 | 10:50AM EST
  42. Early Gains Fizzle, Turn Mixed; Biogen, Ferrari Rise

    IBD | Oct. 21, 2015 | 10:47AM EST
  43. Benzinga's Top #PreMarket Gainers

    Benzinga | Oct. 21, 2015 | 08:19AM EST
  44. Earnings Scheduled For October 21, 2015

    Benzinga | Oct. 21, 2015 | 04:09AM EST
  45. Fast Money Picks For October 20

    Benzinga | Oct. 20, 2015 | 06:59AM EST
  46. Stock Week Ahead: Housing Data, Broad-Based Earnings Line Up

    Benzinga | Oct. 19, 2015 | 14:52PM EST
  47. Why Rental Rates At Biotech Labs Are Skyrocketing

    IBD | Oct. 15, 2015 | 15:50PM EST
  48. Valeant Subpoenaed By Federal Prosecutors On Pricing

    IBD | Oct. 15, 2015 | 09:12AM EST
  49. Valeant Subpoenaed By Federal Prosecutors On Pricing

    IBD | Oct. 14, 2015 | 23:12PM EST
  50. Market Has Overreacted in Biogen

    GuruFocus | Oct. 14, 2015 | 14:39PM EST
Trading Center